Production & Manufacturing

Analysis of the chemical and physical methodologies employed to overcome solubility and permeability barriers, ensuring active pharmaceutical ingredients reach systemic circulation effectively.

Exploration of how sophisticated delivery mechanisms enhance medical efficacy, reduce side effects, and enable personalized treatment across oncology, neurology, and chronic disease management.

Halo Pharma becomes dedicated North American drug product CDMO after emerging as a standalone contract development and manufacturing organization focused exclusively on drug product services in North America. The transition follows SK Capital Partners’ decision to divest the active...

Vetter Pharma manufacturing site in Germany plans have been confirmed as the pharmaceutical service provider moves forward with building a new commercial production facility in the Saarland region of southwest Germany. The company said construction is scheduled to begin...

Over more than ten years working in healthcare, medical manufacturing, and life sciences, it’s clear how much the industry has developed and adapted. One of the biggest shifts has been the focus on sustainability. What used to be a...

Understanding the critical role of containment isolators, biosafety cabinets, and specialized infrastructure in protecting operators and maintaining product integrity during high-potency API manufacturing requires examining regulatory frameworks, engineering controls, and facility design principles that define modern pharmaceutical safety standards.

Modern pharmaceutical manufacturing demands adaptable infrastructure capable of rapid reconfiguration to accommodate changing production requirements, making modular and portable laboratory equipment essential for contract manufacturers, clinical trial operations, and organizations pursuing capacity expansion through scalable platform technologies.